2023
DOI: 10.1111/bcp.15983
|View full text |Cite
|
Sign up to set email alerts
|

Confounding mitigation for the exposure‐response relationship of bevacizumab in colorectal cancer patients

Sarah Lobet,
Morgane Caulet,
Gilles Paintaud
et al.

Abstract: AimsThe exposure‐response relationship of bevacizumab may be confounded by various factors, including baseline characteristics, time‐dependent target engagement and recursive relationships between exposure and response, requiring effective mitigation. This study aimed to investigate the exposure‐response relationships of bevacizumab in metastatic colorectal cancer (mCRC) patients while mitigating potential biases.MethodsBevacizumab pharmacokinetics was described using target‐mediated drug disposition modelling… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 56 publications
0
0
0
Order By: Relevance